Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MUTU: CHW-led Hypertension Management in Nepal
NCT04521582Completed
- Sponsor
- Johns Hopkins Bloomberg School of Public Health
- Start
- Apr 2021
- Primary completion
- Apr 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of amlodipine in hypertension (HTN) (2 arms), sponsored by Johns Hopkins Bloomberg School of Public Health. Primary endpoints: Mean change in systolic blood pressure at 1 year and Mean change in diastolic blood pressure at 1 year. Started Apr 2021; status: completed.
02
Drugs
amlodipine
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT04521582.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04521582.